Clinical Talks
PET amyloid imaging in clinical trials | Vendor Workshop at RSNA 2024
Jacob Dubroff, MD, PhD, associate professor of radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Amyloid PET in the diagnosis and management of patients with suspected Alzheimer disease | Vendor Workshop at RSNA 2024
Jana Ivanidze, MD, PhD, associate professor of radiology, Weill Cornell Medical College, New York, New York, USA
The exploration of ultra-low dose PET/CT and its implications for patient care | Vendor Workshop at RSNA 2024
Eliot Siegel, MD, medical director at United Theranostics, Minneapolis, Minnesota, USA
A powerful bond for cancer treatment: Incorporating molecular imaging with nuclear therapeutics | Vendor Workshop at RSNA 2024
Prostate cancer radiopharmaceutical therapy: Beyond the basic | Vendor Workshop at RSNA 2023
Joseph R. Osborne, MD, PhD, Chief, Molecular Imaging and Therapeutics, Professor of Radiology, Director of the Radiology Health Equity Lab at New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New. York, USA.
PSMA PET: Technical and clinical case review | Vendor Workshop at RSNA 2023
Nicholas Feinberg, MD, Assistant Professor of Radiology, University of Chicago Medicine, Chicago, Illinois, USA.
Timing is of the essence: Unlocking the potential of PET/CT imaging with time of flight
Dr. Ian Armstrong, Nuclear Medicine Consultant Physicist, Manchester University NHS Foundation Trust, United Kingdom.
The potential Impact of Total Body PET to Whole Person Research and Network Medicine
Discover how Prof. Dr. Marcus Hacker envisions the potential of Total Body PET for whole person research and its effects on network medicine.
Symbia Pro.specta: Putting the "Pro" in SPECT/CT imaging
Empowering precision oncology: Expanding access to next-generation theranostics
Clinical experience of routine SPECT/CT reading after migrating from Symbia.net to syngo.via
Artificial intelligence in breast imaging: chances, challenges, and concerns
The expert panel with Prof. Dr. Sylvia Heywang-Köbrunner, Dr. Solveig Hofvind and Dr. Ritse Mann shed light on the role of Artificial Intelligence in the clinical routine of breast cancer screening and diagnostics. They discuss the chances, challenges, and concerns that put the use of AI in mammography and tomosynthesis to the test. (ECR, March, 2023)
The latest on contrast media examinations in breast imaging - Interview
Dr. Ritse Mann, Dr. Panagiotis Kapetas, Dr. Paola Clauser and Prof. Dr. Isabelle Thomassin-Naggara address current clinical and scientific results of contrast media-based imaging in breast diagnostics in the fields of ultrasound, mammography, and magnetic resonance imaging. (ECR, March, 2023)
The latest on contrast media examinations in breast imaging - Interview
Dr. Ritse Mann gives an answer on the current European recommendations for contrast media examinations and the associated political issues. (ECR, March, 2023)
Artificial intelligence in breast imaging: chances, challenges, and concerns - Interview
Dr. Ritse Mann summarizes the chances, challenges and concerns related to Artificial Intelligence in breast imaging, screening and diagnostics. (ECR, March, 2023)